Divya Shankar
Overview
Explore the profile of Divya Shankar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sundaram K, Ahmad Zaki R, Shankar D, Hoe V, Ahmad N, Kuan W, et al.
Cureus
. 2024 Oct;
16(10):e71610.
PMID: 39417069
This systematic review aimed to assess the association between video-observed therapy (VOT) and treatment adherence among TB patients and the benefits and limitations of this treatment modality. The systematic review...
2.
Gardezi M, Shankar D, Suchdev K
Neurohospitalist
. 2024 Apr;
14(2):218-219.
PMID: 38666274
No abstract available.
3.
Kearney C, Sangani R, Shankar D, OConnor G, Law A, Walkey A, et al.
Ann Am Thorac Soc
. 2024 Jan;
21(6):866-874.
PMID: 38241013
The comparative effectiveness of biologic agents used as add-on therapy in the management of difficult-to-control asthma is unclear. To compare the effectiveness of dupilumab, mepolizumab, and benralizumab among patients with...
4.
Bangudi S, Stanek C, Shankar D, Hart L, Nahata L, Cronin R, et al.
Pediatr Blood Cancer
. 2023 Dec;
71(2):e30784.
PMID: 38037196
Depression may contribute to transition risk among young adults with sickle cell disease (SCD). It is unclear if they receive depression screening because primary care providers (PCPs) routinely perform this...
5.
Shankar D, Stanek C, Bangudi S, Liles S, Colton Z, Hart L, et al.
Blood Adv
. 2023 Sep;
7(21):6668-6671.
PMID: 37722355
No abstract available.
6.
Shankar D, Merchand-Reyes G, Buteyn N, Santhanam R, Fang H, Kumar K, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108786
Overactivation of immune responses is a hallmark of autoimmune disease pathogenesis. This includes the heightened production of inflammatory cytokines such as Tumor Necrosis Factor α (TNFα), and the secretion of...
7.
Kathuria H, Shankar D, Cobb V, Newman J, Bulekova K, Werntz S, et al.
JMIR Form Res
. 2022 Sep;
6(9):e36919.
PMID: 36048509
Background: Individuals with opioid use disorder (OUD) have a high prevalence of smoking and frequently experience unmet social determinants of health (SDOH), which may be barriers to smoking cessation. Hospitalization...
8.
Shankar D, Borrelli B, Cobb V, Quintiliani L, Palfai T, Weinstein Z, et al.
BMC Public Health
. 2022 Apr;
22(1):668.
PMID: 35387648
Introduction: Individuals with opioid use disorder (OUD) who smoke cigarettes have high tobacco-related comorbidities, lack of access to tobacco treatment, lack of inclusion in smoking cessation trials, and remain understudied...
9.
Bhat S, Altajar S, Shankar D, Zahorian T, Robert R, Qazi T, et al.
J Manag Care Spec Pharm
. 2020 Apr;
26(4):410-416.
PMID: 32223602
Background: In 2016, the FDA approved infliximab-dyyb (IFX-dyyb) as a biosimilar to infliximab (IFX). Deemed to have comparable efficacy and safety to IFX, IFX-dyyb is 20%-30% less expensive, allowing significant...
10.
Subramanian R, Shankar D, Sebe N, Melcher D
J Vis
. 2014 Mar;
14(3):31.
PMID: 24672021
A basic question in vision research regards where people look in complex scenes and how this influences their performance in various tasks. Previous studies with static images have demonstrated a...